M
Exchange
—
Entity type
operating
Fiscal year end
Jun 30
Headquarters
DE
Recent Filings
- 416.5 KBMyrexis, Inc.Aug 17, 6:07 PM ET·0000921895-21-002138
- 34.9 KBMyrexis, Inc.Mar 31, 6:30 PM ET·0000921895-20-000957
- 10-K/A567.1 KBMyrexis, Inc.Jul 26, 9:47 AM ET·0000921895-13-001482
- 10-K8.0 MBMyrexis, Inc.Jul 17, 4:00 PM ET·0001144204-13-039919
- 10-Q2.5 MBMyrexis, Inc.May 10, 9:17 AM ET·0001144204-13-027684
- 8-K122.9 KBMyrexis, Inc.Apr 29, 5:06 PM ET·0000921895-13-000885
- 8-K40.7 KBMyrexis, Inc.Apr 18, 12:32 PM ET·0000921895-13-000823
- 36.3 KBMyrexis, Inc.Mar 11, 9:02 PM ET·0000921895-13-000546
- SC 13D228.5 KBMyrexis, Inc.Mar 11, 5:23 PM ET·0000921895-13-000543
- 8-K40.9 KBMyrexis, Inc.Mar 5, 5:10 PM ET·0000921895-13-000503
Insiders
10- Aryeh JasonDirector
- Belle Gerald P.Director
- Berry BarbaraSVP, Human Resources
- BREWER RICHARD BDirector, President and CEO
- COUCHMAN JONATHANDirector, Chairman, President and CEO
- First Eagle Investment Management, LLC10% Owner
- Forrester RobertDirector
- Franson Timothy RDirector
- Gibbs AndrewVice President, Legal
- GRYSKA DAVID WDirector, Chief Operating Officer
Tickers
No tickers on record
Addresses
business
600 FIFTH AVENUE, 2ND FLOOR
NEW YORK, NY, 10020
mailing
600 FIFTH AVENUE, 2ND FLOOR
NEW YORK, NY, 10020
Former Names
- Myriad Pharmaceuticals, Inc.2010-06-18